Overview

Tranexamic Acid in Vaginal Reconstructive Surgery

Status:
WITHDRAWN
Trial end date:
2025-01-27
Target enrollment:
Participant gender:
Summary
Tranexamic acid (TXA) has been demonstrated to reduce blood loss in trauma, orthopedic, cardiac, and plastic surgeries in numerous well-designed and adequately powered studies. As a result of this evidence for benefit, TXA is routinely used to reduce blood loss during these surgeries. There are no studies regarding the use of TXA in urogynecology. The investigators seek to explore the effect and safety of local infiltration of TXA in vaginal reconstructive surgery.
Phase:
PHASE4
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Collaborators:
MOUNT SINAI HOSPITAL
The University of Texas Health Science Center, Houston
Treatments:
Arginine Vasopressin
Sodium Chloride
Tranexamic Acid
Vasopressins